M. Lapeyre - Concepedia

Author

M. Lapeyre

Also Known As

Bitdeli Chef, LAPEYRE, MICHEL, Lapeyre, Matthieu, M Lapeyre, M. Lapeyre, M. Ángeles Hierro Lapeyre, MATTHIEU LAPEYRE, Mathieu Lapeyre, Matthieu Lapeyre, Michel Lapeyre

346

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Centre Jean Perrin Institut Gustave Roussy Délégation Centre-Est Inserm Université Clermont Auvergne

About

M. Lapeyre is an author at Centre Jean Perrin specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	46	2.8K
2	Health Sciences	15	20	1.4K
3	Education	1	1	14
4	Engineering	1	1	14
5	Public Health	1	1	19

M. Lapeyre

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial Jean Bourhis, Christian Sire, P. Gräff, The Lancet Oncology Advanced HeadRadiation TherapyMedicineGortec 99-02Head And Neck Cancer	2012	372
Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update J. Biau, M. Lapeyre, I. Troussier, Radiotherapy and Oncology Adaptive RadiotherapyRadiation TherapyMedicineDefinitive HeadNeck Radiation Therapy	2019	233
Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer Marie-Christine Kaminsky-Forrett, T. Conroy, Élisabeth Luporsi, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation TherapyMedicineSurgeryPrognostic Implications	1998	201
Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study) Sophie Jacob, J. Camilleri, S. Derreumaux, Radiation Oncology	2019	171
Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial Jean Bourhis, M. Lapeyre, J. Tortochaux, Journal of Clinical Oncology	2006	151
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial Lionnel Geoffrois, Laurent Martin, D. De Raucourt, Journal of Clinical Oncology	2018	143
Outcomes of secondary interventions after abdominal aortic aneurysm endovascular repair Jean‐Pierre Becquemin, Lynne Kelley, Thomasz Zubilewicz, Journal of Vascular Surgery Endovascular TechniqueSecondary InterventionsVascular SurgeryOutcomes ResearchOpen Procedure	2004	142
Impact of Intensity-Modulated Radiotherapy on Health-Related Quality of Life for Head and Neck Cancer Patients: Matched-Pair Comparison with Conventional Radiotherapy P. Gräff, M. Lapeyre, Emmanuel Désandes, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyQuality Of LifeOncologyRadiation TherapyConventional Radiotherapy	2007	132
Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03 I. Toledano, P. Gräff, Antoine Serre, Radiotherapy and Oncology Radiation MedicineNeck CancerRadiation TherapyMedicineIntensity-modulated Radiotherapy	2012	130
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study Jean-Claude Horiot, F. Lipinski, S Schraub, Radiotherapy and Oncology Radiation MedicineRadiation TherapyMedicineRadiopharmaceutical TherapySurgery	2000	100

Page 1